Jennison Associates
AZN icon

Jennison Associates’s AstraZeneca AZN Stock Holding History

Jennison Associates’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-557,500
Closed -$38M – 652
2017
Q2 		$38M Buy
557,500
+207,500
+59% +$13.6M 0.04% 309
2017
Q1 		$21.8M Buy
+350,000
New +$20.4M 0.02% 410

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Jennison Associates's AZN Position: Q1 2026 in Review

Jennison Associates reduced its AstraZeneca (AZN) stake by 61% in Q1 2026, selling an estimated $196M and leaving 663,945 shares worth $131M. The position accounts for 0.09% of the portfolio, ranked #103.

Jennison Associates first reported a position in AZN in Q1 2014 and has held it in 44 quarters since. The position peaked at $2.07B in Q2 2020. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Jennison Associates held 663,945 shares of AstraZeneca worth $131M as of Q1 2026.
  • Jennison Associates sold 1,017,478 AstraZeneca shares in Q1 2026, an estimated $196M.
  • AstraZeneca made up 0.09% of Jennison Associates's portfolio in Q1 2026, its #103 holding.
  • Jennison Associates first reported a position in AstraZeneca in Q1 2014 and has held it in 44 quarters since.
  • Jennison Associates's AstraZeneca position peaked at $2.07B in Q2 2020.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.